Science

Mar 25, 2025, 09:54

Myeloma Paper of the Day, March 25th, suggested by Robert Orlowski

Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day: CASSIOPEIA MRD data show dara maintenance improved MRD-negative rates vs. observation regardless of induction/consol. or risk status; D-VTd – dara produced highest landmark, accumulative and sustained MRD-negativity and PFS.”

“Daratumumab-Bortezomib-Thalidomide-Dexamethasone for Newly Diagnosed Myeloma: CASSIOPEIA Minimal Residual Disease Results”

Authors: Jill Corre, Laure Vincent, Philippe Moreau, Benjamin Hebraud, Cyrille Hulin, Fredrik Borgsten, Melissa Rowe, Robin Carson, Soraya Wuilleme, Pieter Sonneveld et al.

More posts featuring Robert Orlowski.

Benjamin Hebraud cancer CASSIOPEIA Cyrille Hulin Fredrik Borgsten Jill Corre Laure Vincent Melissa Rowe Myeloma Myeloma Paper of the Day OncoDaily Oncology Philippe Moreau Pieter Sonneveld Robert Orlowski Robin Carson Soraya Wuillème

Neuroendocrine Lung Tumors: Types, Symptoms, Diagnosis, Treatment and 2025 updates

Cancer Center Near Me: Dana-Farber Cancer Institute

FDA Approves Nivolumab and Ipilimumab for First-Line Treatment of Unresectable Hepatocellular Carcinoma Based on CheckMate-9DW Trial

John Cena Announces He Overcame Skin Cancer Twice, Advocates for Sun Safety

William N. Hait to Receive 2025 AACR-Margaret Foti Award for Leadership in Cancer Research